Literature DB >> 7927691

Development of large intestinal attaching and effacing lesions in pigs in association with the feeding of a particular diet.

N A Neef1, S McOrist, R J Lysons, A P Bland, B G Miller.   

Abstract

Hysterotomy-derived piglets were kept in gnotobiotic isolators and artificially colonized at 7 days of age with an adult bovine enteric microflora. At 3 weeks of age, the pigs were transferred to conventional experimental accommodation and weaned, either onto a solid diet that had been associated with field cases of typhlocolitis in pigs or onto a solid control diet. At necropsy at 5 weeks of age, groups of pigs fed the diet associated with field cases of typhlocolitis were found to have developed typhlocolitis. This was absent from the groups fed the control diet. The typhlocolitis was characterized by attaching and effacing lesions typical of those described following experimental inoculation of various species with enteropathogenic Escherichia coli. A nonverocytotoxic, eae probe-positive E. coli serotype O116 was isolated from pigs on the colitis-associated diet but not from any of the pigs on the control diet. Coliform bacteria attached to the colonic lesions reacted with polyclonal antiserum to E. coli O116 in an immunoperoxidase assay of histological sections of affected tissue. No reaction with this antiserum was observed in corresponding tissue sections taken from pigs on the control diet. No colon lesions were observed in germfree pigs fed either of the diets. It is postulated that proliferation and possibly expression of pathogenicity of the attaching and effacing E. coli responsible for the lesions are strongly influenced by diet.

Entities:  

Mesh:

Year:  1994        PMID: 7927691      PMCID: PMC303112          DOI: 10.1128/iai.62.10.4325-4332.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  Diagnosis of colitis in pigs.

Authors:  A L Duncan; R J Lysons
Journal:  Vet Rec       Date:  1987-10-31       Impact factor: 2.695

2.  Grower scour/non-specific colitis.

Authors:  W J Smith; E P Nelson
Journal:  Vet Rec       Date:  1987-10-03       Impact factor: 2.695

3.  The significance of Escherichia Coli to the young pig.

Authors:  R Kenworthy; W D Allen
Journal:  J Comp Pathol       Date:  1966-01       Impact factor: 1.311

4.  A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells.

Authors:  A E Jerse; J Yu; B D Tall; J B Kaper
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

5.  Attaching and effacing Escherichia coli infection as a cause of diarrhea in young calves.

Authors:  B H Janke; D H Francis; J E Collins; M C Libal; D H Zeman; D D Johnson; R D Neiger
Journal:  J Am Vet Med Assoc       Date:  1990-03-15       Impact factor: 1.936

6.  Diarrhea due to Escherichia coli in the rabbit: a novel mechanism.

Authors:  J R Cantey; R K Blake
Journal:  J Infect Dis       Date:  1977-03       Impact factor: 5.226

7.  Studies in gnotobiotic piglets on non-O157:H7 Escherichia coli serotypes isolated from patients with hemorrhagic colitis.

Authors:  S Tzipori; K I Wachsmuth; J Smithers; C Jackson
Journal:  Gastroenterology       Date:  1988-03       Impact factor: 22.682

8.  Comparison in gnotobiotic pigs of lesions caused by verotoxigenic and non-verotoxigenic Escherichia coli.

Authors:  G A Hall; N Chanter; A P Bland
Journal:  Vet Pathol       Date:  1988-05       Impact factor: 2.221

9.  Nature and distribution of mucosal lesions associated with enteropathogenic and enterohemorrhagic Escherichia coli in piglets and the role of plasmid-mediated factors.

Authors:  S Tzipori; R Gibson; J Montanaro
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

10.  Sensitisation of preruminant calves and piglets to antigenic protein in early weaning diets: control of the systemic antibody responses.

Authors:  L M Heppell; J W Sissons; S M Banks
Journal:  Res Vet Sci       Date:  1989-09       Impact factor: 2.534

View more
  7 in total

1.  Experimental infection of newly weaned pigs with human and porcine strains of Serpulina pilosicoli.

Authors:  D J Trott; C R Huxtable; D J Hampson
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

2.  Emergence of a Multidrug-Resistant Shiga Toxin-Producing Enterotoxigenic Escherichia coli Lineage in Diseased Swine in Japan.

Authors:  Masahiro Kusumoto; Yuna Hikoda; Yuki Fujii; Misato Murata; Hirotsugu Miyoshi; Yoshitoshi Ogura; Yasuhiro Gotoh; Taketoshi Iwata; Tetsuya Hayashi; Masato Akiba
Journal:  J Clin Microbiol       Date:  2016-02-10       Impact factor: 5.948

3.  The established intimin receptor Tir and the putative eucaryotic intimin receptors nucleolin and beta1 integrin localize at or near the site of enterohemorrhagic Escherichia coli O157:H7 adherence to enterocytes in vivo.

Authors:  James F Sinclair; Evelyn A Dean-Nystrom; Alison D O'Brien
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

4.  Vaccination of pregnant dams with intimin(O157) protects suckling piglets from Escherichia coli O157:H7 infection.

Authors:  Evelyn A Dean-Nystrom; Lisa J Gansheroff; Melody Mills; Harley W Moon; Alison D O'Brien
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

5.  Direct detection of eae-positive bacteria in human and veterinary colorectal specimens by PCR.

Authors:  A L Hubbard; D J Harrison; C Moyes; S McOrist
Journal:  J Clin Microbiol       Date:  1998-08       Impact factor: 5.948

Review 6.  Swine dysentery: aetiology, pathogenicity, determinants of transmission and the fight against the disease.

Authors:  Avelino Alvarez-Ordóñez; Francisco Javier Martínez-Lobo; Héctor Arguello; Ana Carvajal; Pedro Rubio
Journal:  Int J Environ Res Public Health       Date:  2013-05-10       Impact factor: 3.390

Review 7.  Attaching-effacing bacteria in animals.

Authors:  A D Wales; M J Woodward; G R Pearson
Journal:  J Comp Pathol       Date:  2005-01       Impact factor: 1.311

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.